Quantinno Capital Management LP Takes $1.38 Million Position in Everus (NYSE:ECG)

Quantinno Capital Management LP purchased a new stake in shares of Everus (NYSE:ECG - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 20,932 shares of the company's stock, valued at approximately $1,376,000.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Vanguard Group Inc. purchased a new position in shares of Everus during the 4th quarter valued at $365,965,000. Dimensional Fund Advisors LP bought a new stake in Everus in the fourth quarter worth $120,578,000. Invesco Ltd. bought a new stake in Everus in the fourth quarter worth $65,337,000. Alliancebernstein L.P. bought a new stake in Everus in the fourth quarter worth $53,131,000. Finally, American Century Companies Inc. bought a new stake in Everus in the fourth quarter worth $49,650,000.

Wall Street Analysts Forecast Growth

ECG has been the subject of a number of recent research reports. Stifel Nicolaus upped their price objective on shares of Everus from $55.00 to $71.00 and gave the stock a "buy" rating in a report on Friday, May 16th. DA Davidson upped their price objective on shares of Everus from $58.00 to $68.00 and gave the stock a "neutral" rating in a report on Thursday, May 15th.

Everus Price Performance

Shares of NYSE:ECG opened at $57.70 on Friday. The company has a current ratio of 1.58, a quick ratio of 1.50 and a debt-to-equity ratio of 0.47. Everus has a 1 year low of $31.38 and a 1 year high of $77.93. The firm has a fifty day moving average price of $42.64 and a 200 day moving average price of $54.42.

Everus (NYSE:ECG - Get Free Report) last released its earnings results on Tuesday, May 13th. The company reported $0.72 earnings per share for the quarter, topping analysts' consensus estimates of $0.43 by $0.29. The firm had revenue of $826.63 million for the quarter, compared to analyst estimates of $676.35 million. Everus's revenue for the quarter was up 32.1% on a year-over-year basis. On average, equities analysts expect that Everus will post 2.49 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Edward A. Ryan bought 1,400 shares of the business's stock in a transaction on Tuesday, February 25th. The stock was purchased at an average price of $38.02 per share, with a total value of $53,228.00. Following the transaction, the director now directly owns 14,928 shares in the company, valued at approximately $567,562.56. The trade was a 10.35% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Maximillian J. Marcy acquired 1,300 shares of the business's stock in a transaction dated Tuesday, February 25th. The shares were bought at an average cost of $38.99 per share, with a total value of $50,687.00. Following the transaction, the chief financial officer now directly owns 5,508 shares of the company's stock, valued at $214,756.92. The trade was a 30.89% increase in their position. The disclosure for this purchase can be found here. Company insiders own 0.21% of the company's stock.

Everus Profile

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.

Want to see what other hedge funds are holding ECG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Everus (NYSE:ECG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.